| P50 | author | Bert W. O'Malley | Q827492 |
| P2093 | author name string | Daqing Li | |
| | Wei Guang | |
| | Koichiro Saito | |
| | Koji Araki | |
| | Nishant Reddy | |
| P2860 | cites work | Dendritic cells and the control of immunity | Q27860918 |
| | Cancer statistics, 2007 | Q29547293 |
| | Ablative therapies for the treatment of malignant diseases of the breast | Q33215655 |
| | Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer | Q33363075 |
| | The potential for monocyte-mediated immunotherapy during infection and malignancy. Part I: apoptosis induction and cytotoxic mechanisms | Q33647904 |
| | Phagocyte recognition of cells undergoing apoptosis | Q34355692 |
| | Radiofrequency ablation for chronic pain control | Q34417812 |
| | Spinning molecular immunology into successful immunotherapy | Q34632056 |
| | Percutaneous radiofrequency treatment of osteoid osteoma | Q34802471 |
| | A potential role of macrophage activation in the treatment of cancer | Q34987424 |
| | Adrenal-preserving minimally invasive surgery: the role of laparoscopic partial adrenalectomy, cryosurgery, and radiofrequency ablation of the adrenal gland | Q35049591 |
| | Gene-based vaccines and immunotherapeutics | Q35873176 |
| | Radiofrequency ablation of liver tumours: systematic review | Q35874711 |
| | Radiofrequency ablation of cancer | Q35895377 |
| | Review of radiofrequency ablation for renal cell carcinoma | Q35901591 |
| | Radiofrequency ablation of lung malignancies: where do we stand? | Q35971437 |
| | Treatment of recurrent head and neck cancer: re-irradiation or chemotherapy? | Q36131265 |
| | Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses | Q36365628 |
| | Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells | Q36375909 |
| | High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes | Q36380488 |
| | T cells and lymphokines | Q38737937 |
| | The CTL's kiss of death | Q40399827 |
| | In situ tumor ablation creates an antigen source for the generation of antitumor immunity | Q40550098 |
| | Therapeutic efficiency of IL-2 gene transduced tumor vaccine for head and neck carcinoma | Q40885287 |
| | Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 |
| | Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs | Q41057373 |
| | The role of interleukin-2 in combination adenovirus gene therapy for head and neck cancer | Q41108368 |
| | A new immunocompetent murine model for oral cancer | Q41142495 |
| | Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically | Q42389372 |
| | The effect of preoperative local interleukin-2 (IL-2) injections in patients with head and neck squamous cell carcinoma. An immunological study | Q42477173 |
| | Combination nonviral interleukin 2 gene therapy and external-beam radiation therapy for head and neck cancer | Q45862981 |
| | Combination nonviral interleukin 2 and interleukin 12 gene therapy for head and neck squamous cell carcinoma | Q45881342 |
| | Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of primary tumor: an in situ tumor vaccine? | Q53650343 |
| | A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone | Q68815180 |
| | Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer | Q68815187 |
| | Interleukin-2 and cancer: critical analysis of results, problems and expectations | Q73048395 |
| | Spatial distribution of tumor vaccine improves efficacy | Q73746801 |
| | Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides | Q73899169 |
| | Radiofrequency ablation of head and neck tumors: dramatic results from application of a new technology | Q74690678 |
| | Techniques for radiofrequency ablation of head and neck tumors | Q75296268 |
| P433 | issue | 3 | |
| P921 | main subject | dendritic cell | Q506253 |
| | head and neck cancer | Q1783924 |
| | head and neck carcinoma | Q18554836 |
| | neck cancer | Q18966654 |
| P304 | page(s) | 359-367 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | Head & Neck | Q13703062 |
| P1476 | title | Enhanced local dendritic cell activity and tumor-specific immunoresponse in combined radiofrequency ablation and interleukin-2 for the treatment of human head and neck cancer in a murine orthotopic model | |
| P478 | volume | 33 | |